Alkermes Sustainability Profile
Alkermes plc, a leading biopharmaceutical company headquartered in Ireland, focuses on developing innovative therapies for central nervous system (CNS) disorders and addiction. Founded in 1987, Alkermes has established a strong presence in the global healthcare market, with significant operations in the United States and Europe. The company is renowned for its unique drug delivery technologies and a robust portfolio of products, including treatments for schizophrenia, depression, and opioid dependence. Alkermes' commitment to addressing complex medical needs has positioned it as a key player in the biopharmaceutical industry, with notable achievements in advancing patient care through its proprietary formulations. With a focus on scientific excellence and patient-centric solutions, Alkermes continues to drive innovation and improve outcomes for individuals affected by serious mental health conditions.
DitchCarbon Score
How does Alkermes's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Alkermes's score of 30 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Alkermes's reported carbon emissions
In 2024, Alkermes reported total carbon emissions of approximately 20,000,000 kg CO2e, encompassing both Scope 1 and Scope 2 emissions. This marks a reduction from 2023, where emissions were about 25,000,000 kg CO2e. Over the past few years, Alkermes has demonstrated a commitment to reducing its carbon footprint, with emissions in 2022 reaching about 30,000,000 kg CO2e. The company has not disclosed specific Scope 3 emissions data, nor has it set formal reduction targets through initiatives such as the Science Based Targets initiative (SBTi). However, it continues to monitor its emissions and has reported various metrics, including emissions per employee and emissions per million dollars of revenue, which were approximately 10,000 kg CO2e and 0.00001 kg CO2e, respectively, in 2024. Alkermes's headquarters is located in Ireland (IE), and it operates with a focus on sustainability, although specific reduction initiatives or pledges have not been detailed in the available data. The emissions data is sourced directly from Alkermes plc, with no cascaded data from parent or related organizations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 13,960,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | - | - |
| Scope 2 | 17,785,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | - | - |
| Scope 3 | - | - | - | - | - | - | - | - | - | - |
How Carbon Intensive is Alkermes's Industry?
How Carbon Intensive is Alkermes's Location?
Alkermes's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Alkermes has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Reckitt
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.